54% of Men Still Want PSA Testing Despite Guidance, Risks

Share this content:
Men Still Want PSA Testing Despite Guidance, Risks
Men Still Want PSA Testing Despite Guidance, Risks

(HealthDay News) -- The October 2011 U.S. Preventive Services Task Force (USPSTF) recommendation advising against prostate-specific antigen (PSA) testing may be met with resistance by men, according to a study published online July 9 in the American Journal of Preventive Medicine.

Linda B. Squiers, Ph.D., from RTI International in Rockville, Md., and colleagues analyzed data from a web survey of men aged 40 to 74 years that was conducted from Nov. 22 to Dec. 2, 2011.

The researchers found that, of 1,089 male respondents without a history of prostate cancer, 62% agreed with the recommendation against PSA testing. Disagreement with the recommendation was significantly associated with age and worry about getting prostate cancer.

Thirteen percent of respondents planned to follow the USPSTF recommendation and not get a PSA test in the future; 54% did not plan to follow the recommendation and did plan to get a PSA test in the future; and 33% were undecided. Not intending to follow the guidelines was positively associated with black race, higher income, having a PSA test in the past 2 years, and being somewhat/very worried about getting prostate cancer.

"We need to do a better job of presenting both the benefits and harms of screening to all patients and explaining the science behind the recommendation in plain language so everyone can understand it," Squiers said in a statement.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs